Combretastatin A-1

• Description :

  Combretastatin A-1 is a potent microtubule inhibitor with anti-tumour and anti-vascular activity, acting through microtubule protein depolymerisation-mediated inactivation of AKT to inhibit the Wnt/β-catenin pathway, and can be used to study hepatocellular carcinoma.

• CAS Number :

  109971-63-3

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  332.35

• Molecular Formula :

  C18H20O6

• Notes :

  Research use only, not for human use.

• Receptor :

  Microtubule Associated | Akt